Entity
  • Eisai US

    Created in 1995
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    6,634 127,374 20,765
  • Entity types

  • Location

    200 Metro Blvd, Nutley, NJ 07110, USA

    Nutley

    United States of America

  • Employees

    Scale: 1001-5000

    Estimated: 2,900

  • Engaged corporates

    23
    5 14
  • Added in Motherbase

    2 years, 10 months ago
Description
  • Value proposition

    Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: https://bit.ly/3dkY

    At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.

    Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US.

    Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.

    Neurology, Gastroenterology, Alzheimer's disease, Oncology, Epilepsy, Insomnia, Metastatic breast cancer, renal cell carcinoma, hepatocellular carcinoma, dementia, and endometrial cancer

  • A human-centered pharmaceutical company | Eisai US

    We are dedicated to transforming drug discovery by developing targeted treatments for challenging neurological conditions and driving innovations toward a cancer-free future.

  • https://us.eisai.com/
Corporate interactions BETA
Corporate TypeTweets Articles
FirstWord Pharma
FirstWord Pharma
Pharmaceutical, Pharmaceutical Manufacturing
FirstWord Pharma
Pharmaceutical, Pharmaceutical Manufacturing
Other

15 Dec 2017


IBM
IBM
IT services, IT Services and IT Consulting
IBM
IT services, IT Services and IT Consulting
Other

26 Jun 2020


OECD - OCDE
OECD - OCDE
International development, International Affairs
OECD - OCDE
International development, International Affairs
Other

1 Nov 2022


Similar entities
AxisEntities
No similarities
Eisai US
2 months ago 22

Our Government Affairs & Policy team had the privilege of visiting the Iona Senior Services Washington Home Center, a daytime respite facility for seniors living with cognitive impairment.

During their visit, they connected with participants through engaging activities, including a meet-and-greet, group chair exercises, a reading circle and trivia. These moments of joy and connection reflect our commitment to supporting the well-being of those impacted by #AlzheimersDisease and #dementia.

Our human health care (hhc) mission is at the heart of everything we do. These experiences inspire us to continue to make a true difference for patients. #LifeAtEisai

Eisai US
2 months ago 96

Our Government Affairs & Policy and Advocacy teams hosted their first Advocacy Policy Summit in Washington, D.C., bringing together more than 15 advocacy partners from across our therapeutic areas. The Summit provided a valuable opportunity to better understand the patient care journey and the policy challenges they face.

Several important topics were discussed including the fact that #AlzheimersDisease and #oncology care paradigms have many commonalities, highlighting the need for a unified voice in advancing policy goals.

Thank you to our advocacy partners for their insights and collaboration as we continue working to support patients and care partners. #LifeAtEisai

Eisai US
2 months ago 22

We’re proud to support the James M. Dixon Foundation and their efforts to aid those impacted by #AlzheimersDisease and #dementia. Through the foundation’s Food Insecurities Program, our hhceco Center employees donated pantry staples to help provide nourishment and support to those in need.

In the spirit of Magnolia Meals at Home, our team’s efforts reflect our commitment to the community. Thank you to everyone who made this drive a success! #LifeAtEisai

Eisai US
2 months ago 48 4

At our latest Speaker Series event, a common thread connected many employees — being part of the generation raising children and caring for their aging parents. This group is better known as the “sandwich generation.”

Christy Byrne Yates, M.S., licensed educational psychologist and author, shared insights from her own experience as a mother while being a caregiver to parents living with #dementia. Her strategies and reminders to seek support are explored further in her book “Building a Legacy of Love: Thriving in the Sandwich Generation.”

To all the caregivers in our workforce and the communities we serve: your story matters, and you’re not alone. We remain dedicated to supporting you. #LifeAtEisai

Learn more about Christy’s story here: https://bit.ly/4iZfP71

Eisai US
2 months, 1 week ago 248 5

Our end-of-year All-Employee Meeting brought us together as One Team, where leaders shared key business updates and unveiled our 2025 strategy. We wrapped up the day with our annual holiday party, celebrating our successes and enjoying time with colleagues. It’s always a privilege to get together to reflect on the year and recharge for the future! #LifeAtEisai

Social network dynamics